aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Inotiv, Inc. was founded with the mission to provide comprehensive drug discovery, development, and consulting services to the pharmaceutical and medical device industries. The company operates through two main segments: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). Inotiv offers a range of services including nonclinical and analytical drug discovery, safety assessment, and the manufacturing of scientific instruments and related software for life sciences research. Their market focus includes pharmaceutical companies, universities, government research centers, and medical research institutions.
Notable affiliated individuals include key scientific leaders and experienced professionals in the pharmaceutical and medical device sectors. Inotiv has attracted significant investment from stakeholders interested in advancing drug discovery and development. Key achievements include the development of innovative tools like Target Sufficiency® for quantitative analysis of drug target systems. Overall, Inotiv has made a substantial impact by supporting critical research efforts, reducing costs for clients, and enhancing the efficiency of drug development processes globally.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Drug Discovery, Research Services
Technology
Analytics
Tags
Biotech
Model Types
Professional Services, Research
Revenue Type(s)
Consulting
Customer Type(s)
Enterprise, Government
Geographic Exposure
Global
When was Inotiv founded?
Inotiv was founded in 1974.
Where is Inotiv’s headquarters located?
Inotiv’s headquarters is located in West Lafayette, IN, US.
When was Inotiv’s last funding round?
Inotiv’s most recent funding round was for $41.9k (USD) in June 2022.
How many employees does Inotiv have?
Inotiv has 125 employees as of Feb 6, 2024.
How much has Inotiv raised to-date?
As of July 05, 2023, Inotiv has raised a total of $41.9k (USD) since Jun 20, 2022.
Add Comparison
Total Raised to Date
$41.9k
USD
Last Update Jun 20, 2022
Last Deal Details
$41.9k
USD
Jun 20, 2022
Grant
Total Employees Over Time
125
As of Feb 2024
Inotiv Address
2701 Kent Ave
West Lafayette,
Indiana
47906-1382
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts